drugset / Trial / NCT03270462

CNS Study of Patients Switching From Tacrolimus to Envarsus

NCT03270462 ↗

Phase 4 Completed 20 enrolled University of Colorado, Denver
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study documenting the neurotoxic side effects including tremors in patients with a stable graft who are receiving Tacrolimus following kidney transplantation. A standardized questionnaire will be used to document these symptoms.

Timeline

Start
2017-12-01
Primary completion
2020-05-02
Completion
2020-06-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — —

Indications

No indication recorded.